title: A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist.
abstract: Inflammation, regardless of whether it is provoked by infection or by tissue damage, starts with the activation of macrophages which initiate a cascade of inflammatory responses by producing the cytokines interleukin-1 (IL-1) and tumour necrosis factor-alpha (ref. 1). Three naturally occurring ligands for the IL-1 receptor (IL1R) exist: the agonists IL-1alpha and IL-1beta and the IL-1-receptor antagonist IL1RA (ref. 2). IL-1 is the only cytokine for which a naturally occurring antagonist is known. Here we describe the crystal structure at 2.7 A resolution of the soluble extracellular part of type-I IL1R complexed with IL1RA. The receptor consists of three immunoglobulin-like domains. Domains 1 and 2 are tightly linked, but domain three is completely separate and connected by a flexible linker. Residues of all three domains contact the antagonist and include the five critical IL1RA residues which were identified by site-directed mutagenesis. A region that is important for biological function in IL-1beta, the 'receptor trigger site' is not in direct contact with the receptor in the IL1RA complex. Modelling studies suggest that this IL-1beta trigger site might induce a movement of domain 3.
authors.affiliation: Marion Merrell Dow Research Institute, Strasbourg, France.
authors.forename: H
authors.initials: H
authors.lastname: Schreuder
authors.forename: C
authors.initials: C
authors.lastname: Tardif
authors.forename: S
authors.initials: S
authors.lastname: Trump-Kallmeyer
authors.forename: A
authors.initials: A
authors.lastname: Soffientini
authors.forename: E
authors.initials: E
authors.lastname: Sarubbi
authors.forename: A
authors.initials: A
authors.lastname: Akeson
authors.forename: T
authors.initials: T
authors.lastname: Bowlin
authors.forename: S
authors.initials: S
authors.lastname: Yanofsky
authors.forename: R W
authors.initials: RW
authors.lastname: Barrett
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D016466:CHO Cells; D006224:Cricetinae; D018360:Crystallography, X-Ray; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein; D051379:Mice; D008958:Models, Molecular; D008969:Molecular Sequence Data; D011485:Protein Binding; D011487:Protein Conformation; D017510:Protein Folding; D017472:Receptors, Interleukin-1 / Q000037:antagonists & inhibitors / Q000737:chemistry* / Q000378:metabolism; D011994:Recombinant Proteins / Q000737:chemistry / Q000378:metabolism; D016415:Sequence Alignment; D012795:Sialoglycoproteins / Q000737:chemistry* / Q000378:metabolism
chemical_list: C507763:IL1RN protein, human; C507764:Il1rn protein, mouse; D053590:Interleukin 1 Receptor Antagonist Protein; D017472:Receptors, Interleukin-1; D011994:Recombinant Proteins; D012795:Sialoglycoproteins